BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

571 related articles for article (PubMed ID: 22682223)

  • 1. Analysis of tumor metabolism reveals mitochondrial glucose oxidation in genetically diverse human glioblastomas in the mouse brain in vivo.
    Marin-Valencia I; Yang C; Mashimo T; Cho S; Baek H; Yang XL; Rajagopalan KN; Maddie M; Vemireddy V; Zhao Z; Cai L; Good L; Tu BP; Hatanpaa KJ; Mickey BE; Matés JM; Pascual JM; Maher EA; Malloy CR; Deberardinis RJ; Bachoo RM
    Cell Metab; 2012 Jun; 15(6):827-37. PubMed ID: 22682223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glutamine synthetase activity fuels nucleotide biosynthesis and supports growth of glutamine-restricted glioblastoma.
    Tardito S; Oudin A; Ahmed SU; Fack F; Keunen O; Zheng L; Miletic H; Sakariassen PØ; Weinstock A; Wagner A; Lindsay SL; Hock AK; Barnett SC; Ruppin E; Mørkve SH; Lund-Johansen M; Chalmers AJ; Bjerkvig R; Niclou SP; Gottlieb E
    Nat Cell Biol; 2015 Dec; 17(12):1556-68. PubMed ID: 26595383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucose metabolism via the pentose phosphate pathway, glycolysis and Krebs cycle in an orthotopic mouse model of human brain tumors.
    Marin-Valencia I; Cho SK; Rakheja D; Hatanpaa KJ; Kapur P; Mashimo T; Jindal A; Vemireddy V; Good LB; Raisanen J; Sun X; Mickey B; Choi C; Takahashi M; Togao O; Pascual JM; Deberardinis RJ; Maher EA; Malloy CR; Bachoo RM
    NMR Biomed; 2012 Oct; 25(10):1177-86. PubMed ID: 22383401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolism of [U-13 C]glucose in human brain tumors in vivo.
    Maher EA; Marin-Valencia I; Bachoo RM; Mashimo T; Raisanen J; Hatanpaa KJ; Jindal A; Jeffrey FM; Choi C; Madden C; Mathews D; Pascual JM; Mickey BE; Malloy CR; DeBerardinis RJ
    NMR Biomed; 2012 Nov; 25(11):1234-44. PubMed ID: 22419606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficient Mitochondrial Glutamine Targeting Prevails Over Glioblastoma Metabolic Plasticity.
    Oizel K; Chauvin C; Oliver L; Gratas C; Geraldo F; Jarry U; Scotet E; Rabe M; Alves-Guerra MC; Teusan R; Gautier F; Loussouarn D; Compan V; Martinou JC; Vallette FM; Pecqueur C
    Clin Cancer Res; 2017 Oct; 23(20):6292-6304. PubMed ID: 28720668
    [No Abstract]   [Full Text] [Related]  

  • 6. Acetate is a bioenergetic substrate for human glioblastoma and brain metastases.
    Mashimo T; Pichumani K; Vemireddy V; Hatanpaa KJ; Singh DK; Sirasanagandla S; Nannepaga S; Piccirillo SG; Kovacs Z; Foong C; Huang Z; Barnett S; Mickey BE; DeBerardinis RJ; Tu BP; Maher EA; Bachoo RM
    Cell; 2014 Dec; 159(7):1603-14. PubMed ID: 25525878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pyruvate carboxylase is required for glutamine-independent growth of tumor cells.
    Cheng T; Sudderth J; Yang C; Mullen AR; Jin ES; Matés JM; DeBerardinis RJ
    Proc Natl Acad Sci U S A; 2011 May; 108(21):8674-9. PubMed ID: 21555572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucose fluxes in glycolytic and oxidative pathways detected in vivo by deuterium magnetic resonance spectroscopy reflect proliferation in mouse glioblastoma.
    Simões RV; Henriques RN; Cardoso BM; Fernandes FF; Carvalho T; Shemesh N
    Neuroimage Clin; 2022; 33():102932. PubMed ID: 35026626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Compensatory glutamine metabolism promotes glioblastoma resistance to mTOR inhibitor treatment.
    Tanaka K; Sasayama T; Irino Y; Takata K; Nagashima H; Satoh N; Kyotani K; Mizowaki T; Imahori T; Ejima Y; Masui K; Gini B; Yang H; Hosoda K; Sasaki R; Mischel PS; Kohmura E
    J Clin Invest; 2015 Apr; 125(4):1591-602. PubMed ID: 25798620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microenvironment involved in FPR1 expression by human glioblastomas.
    Boer JC; van Marion DM; Joseph JV; Kliphuis NM; Timmer-Bosscha H; van Strijp JA; de Vries EG; den Dunnen WF; Kruyt FA; Walenkamp AM
    J Neurooncol; 2015 May; 123(1):53-63. PubMed ID: 25894595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beyond aerobic glycolysis: transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis.
    DeBerardinis RJ; Mancuso A; Daikhin E; Nissim I; Yudkoff M; Wehrli S; Thompson CB
    Proc Natl Acad Sci U S A; 2007 Dec; 104(49):19345-50. PubMed ID: 18032601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A plant/fungal-type phosphoenolpyruvate carboxykinase located in the parasite mitochondrion ensures glucose-independent survival of
    Nitzsche R; Günay-Esiyok Ö; Tischer M; Zagoriy V; Gupta N
    J Biol Chem; 2017 Sep; 292(37):15225-15239. PubMed ID: 28726641
    [No Abstract]   [Full Text] [Related]  

  • 13. Dual-targeting of aberrant glucose metabolism in glioblastoma.
    Shen H; Decollogne S; Dilda PJ; Hau E; Chung SA; Luk PP; Hogg PJ; McDonald KL
    J Exp Clin Cancer Res; 2015 Feb; 34(1):14. PubMed ID: 25652202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bevacizumab treatment induces metabolic adaptation toward anaerobic metabolism in glioblastomas.
    Fack F; Espedal H; Keunen O; Golebiewska A; Obad N; Harter PN; Mittelbronn M; Bähr O; Weyerbrock A; Stuhr L; Miletic H; Sakariassen PØ; Stieber D; Rygh CB; Lund-Johansen M; Zheng L; Gottlieb E; Niclou SP; Bjerkvig R
    Acta Neuropathol; 2015 Jan; 129(1):115-31. PubMed ID: 25322816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glioblastoma cells require glutamate dehydrogenase to survive impairments of glucose metabolism or Akt signaling.
    Yang C; Sudderth J; Dang T; Bachoo RM; McDonald JG; DeBerardinis RJ
    Cancer Res; 2009 Oct; 69(20):7986-93. PubMed ID: 19826036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic heterogeneity and plasticity of glioma stem cells in a mouse glioblastoma model.
    Shibao S; Minami N; Koike N; Fukui N; Yoshida K; Saya H; Sampetrean O
    Neuro Oncol; 2018 Feb; 20(3):343-354. PubMed ID: 29016888
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-153 regulates glutamine metabolism in glioblastoma through targeting glutaminase.
    Liu Z; Wang J; Li Y; Fan J; Chen L; Xu R
    Tumour Biol; 2017 Feb; 39(2):1010428317691429. PubMed ID: 28218035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The angiogenic switch leads to a metabolic shift in human glioblastoma.
    Talasila KM; Røsland GV; Hagland HR; Eskilsson E; Flønes IH; Fritah S; Azuaje F; Atai N; Harter PN; Mittelbronn M; Andersen M; Joseph JV; Hossain JA; Vallar L; Noorden CJ; Niclou SP; Thorsen F; Tronstad KJ; Tzoulis C; Bjerkvig R; Miletic H
    Neuro Oncol; 2017 Mar; 19(3):383-393. PubMed ID: 27591677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brain Tumor Stem Cell Dependence on Glutaminase Reveals a Metabolic Vulnerability through the Amino Acid Deprivation Response Pathway.
    Restall IJ; Cseh O; Richards LM; Pugh TJ; Luchman HA; Weiss S
    Cancer Res; 2020 Dec; 80(24):5478-5490. PubMed ID: 33106333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo characterization of brain metabolism by
    Lai M; Vassallo I; Lanz B; Poitry-Yamate C; Hamou MF; Cudalbu C; Gruetter R; Hegi ME
    Int J Cancer; 2018 Jul; 143(1):127-138. PubMed ID: 29417580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.